- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care Businesses
Eli Lilly's top lawyer to retire at end of year
August 31, 2012
Associated PressIndianapolis-based drugmaker Eli Lilly and Co. said Thursday its general counsel, Robert Armitage, will retire at the end
of the year and be replaced by deputy general counsel Michael Harrington.
MoreLilly stops testing of experimental schizophrenia drug
August 29, 2012
Bloomberg NewsEli Lilly and Co. halted testing on an experimental treatment for schizophrenia after the company determined the drug was
unlikely to show a benefit in patients.
MoreRecords for 55,000 patients stolen from oncology group
August 28, 2012
IBJ StaffThe Cancer Care Group in Indianapolis said a laptop computer bag containing private information on as many as 55,000 patients
has been stolen.
MoreLilly's Alzheimer's finding triggers investor hope, doctor caution
August 27, 2012
Bloomberg NewsWhile investors supported the sliver of promise offered when Eli Lilly and Co. said its Alzheimer’s drug may slow progression
early in the disease, doctors weren’t as impressed, saying it could take years to find out for sure.
MoreLilly wins appeal upholding patent for Alimta cancer drug
August 24, 2012
Bloomberg NewsEli Lilly and Co. won a U.S. appeals court ruling that upholds the validity of a patent for the lung-cancer drug Alimta and
blocks generic competition through 2017. Alimta generated $2.5 billion in sales last year.
MoreAlzheimer's drug results leave Lilly 'excited' but uncertain
August 24, 2012
J.K. WallThe surprise positive effect shown by an experimental Alzheimer’s drug “excited” executives at Eli Lilly
and Co., but it raised as many questions as it answered.
MoreHumane Society clinic to open with even bigger goal in mind
August 22, 2012
Dan HumanThe Humane Society of Indianapolis is ready to open its new Animal Welfare Center in Haughville, featuring a low-cost vaccination
clinic. The group wants to raise $750,000 to add a low-cost spay-and-neuter clinic to the center.
MoreLilly to book $790M Amylin payment in third quarter
August 9, 2012
Associated PressEli Lilly and Co. will book about $790 million in pretax income in the third quarter thanks to an early payment from former
drug development partner Amylin Pharmaceuticals.
MoreLilly stock slips after competitors halt Alzheimer's plans
August 7, 2012
IBJ Staff and Bloomberg NewsPfizer Inc., Johnson & Johnson and Elan Corp. are ending most plans to develop an Alzheimer’s drug after a second
trial failure. Eli Lilly is developing a similar treatment.
MoreCautious hospitals trouble Hill-Rom
July 30, 2012
J.K. WallThe investor drubbing sustained by Hill-Rom Holdings Inc. last week stemmed not so much from the new acquisition it announced
as from the gloomy outlook in the North American hospital market.
MoreCook Medical shelves Midwest expansion plans
July 27, 2012
J.K. Wall
Cook Medical Inc. had been planning to open five new manufacturing plants over the next five years in small communities
around the Midwest, including Indiana, but has shelved those plans because of the hit it will take from a new U.S. tax on
medical devices.
Hill-Rom stock swoons after $400M acquisition
July 26, 2012
Associated PressInvestors reacted negatively Thursday after medical equipment and hospital bed maker Hill-Rom Holdings Inc. on Wednesday said
it was acquiring Aspen Surgical Products for $400 million.
MorePotential Alzheimer’s drug fails first of four key trials
July 24, 2012
Bloomberg NewsBapineuzumab is in a race with a similar product from Indianapolis-based Eli Lilly and Co. to become the first therapy to
target a cause for Alzheimer’s, rather than just its symptoms.
MoreSurvey: Solo practices nearly gone
July 23, 2012
J.K. WallOnly 1 percent of the jobs given to Texas-based Merritt Hawkins over the past year were for solo practitioners, the physician
recruiting firm reported this month. That’s down from 22 percent of all searches in 2004.
MoreWellPoint agrees to pay for 3 children to get gene test
July 12, 2012
Bloomberg NewsWellPoint Inc. said it will pay for DNA testing for three children to see if they have an inherited heart disease their father
suffers from that often strikes without warning, reversing an earlier decision to deny coverage.
MorePotential Lilly antipsychotic falls short in study
July 11, 2012
Associated PressEli Lilly and Co. said a potential treatment for acute schizophrenia failed in a late-stage study that compared patients taking
the drug to those taking a placebo.
MoreCompeting Alzheimer's treatments facing long odds
July 11, 2012
Bloomberg NewsJohnson & Johnson, Pfizer Inc. and Elan Corp are racing Indianapolis-based Eli Lilly and Co. to market the first broadly available
drug designed to target a cause of Alzheimer's, rather than just its symptoms. Analysts say the potential drugs are long shots.
MoreZoeller goes after closed Allcare Dental chain
July 10, 2012
Indiana Lawyer StaffA chain of dental offices that abruptly closed multiple Indiana locations in December 2010 left patients without care, refunds
or records, according to a complaint filed by the Office of the Indiana Attorney General.
MoreLilly gets 6-month Cymbalta marketing extension
July 6, 2012
Associated PressEli Lilly and Co. said Friday that it has received an extra six months of marketing exclusivity on the antidepressant Cymbalta,
its biggest selling drug. The extension could mean more than a billion dollars in sales for the Indianapolis drug maker.
MoreLilly cancer treatment fails trial in stomach cancer
July 5, 2012
IBJ Staff and Bloomberg NewsErbitux, a cancer treatment made by Indianapolis-based Eli Lilly and Co.'s Imclone unit, failed to help patients with
advanced stomach tumors in a late-stage clinical trial.
MoreBristol-Myers to buy former Lilly partner Amylin for $5.3B
June 30, 2012
Bloomberg NewsBristol-Myers Squibb Co. has agreed to pay $5.3 billion to acquire former Eli Lilly and Co. partner Amylin Pharmaceuticals
Inc., a maker of diabetes therapies. The deal is valued at about $7 billion, which includes Amylin’s debt and a payment
to Eli Lilly and Co. of about $1.7 billion.
MoreCovance plans $150M expansion, 465 jobs in Greenfield
June 26, 2012
The New Jersey-based pharmaceutical research company is seeking state and local incentives as part of the expansion, which
would include a new laboratory, set to be finished in 2016. Covance already employs 565 workers at the site.
MoreJ&J, Bayer fail to win U.S. OK for expanded Xarelto use
June 22, 2012
If approved for acute coronary syndrome, Xarelto would compete with Effient from Indianapolis-based Eli Lilly and Co and Brilinta
from London-based AstraZeneca Plc.
MoreMedical startup plans 71 jobs, seeks incentives
June 21, 2012
The city of Indianapolis granted preliminary approval for an eight-year tax abatement to Arcamed Inc., which plans to purchase
$1.4 million in equipment to design and manufacture titanium and case-tray systems for surgical instruments.
MoreLilly resumes $3B stock buyback program, declares dividend
June 19, 2012
Associated PressThe local pharmaceutical giant plans to complete the program started in 2000 by repurchasing $420 million in shares by the
end of the year. And on Tuesday, it declared a regular dividend of 49 cents.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
It's also across the street from Fogo de Chao and Morton's....
Yep, the haters are trying to make good news bad. I guess it is hard to get people to believe the series is dying when they are gaining new sponsors.
David Copperfield! I remember watching his specials on TV when I was little.
Don't forget this is next to an MMA gym, a pawn shop, and some abandoned spaces.
Good project for Zionsville - A group who has owned the property for many years has waited and worked patiently to bring highest and best use development to a major corridor, and mix that in with the great downtown you have. Win Win. All the Best to Pittman Partners and Zionsville.